Lifestance Health Group Inc (LFST) Stock Forecast & Price Target
Lifestance Health Group Inc · NASDAQ
$11.25+0.37 (+3.40%)
15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 8 firms covering Lifestance Health Group Inc, 6 rate it Buy or better, 2 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets span $8.00 to $15.00, a moderate spread. The average target of $11.50 sits 2% above the current $11.25. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $0.07 next quarter toward $0.39 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS8 ratings
Moderate Buy
Strong Buy00%
Buy675%
Hold225%
Sell00%
Strong Sell00%
Based on 8 analysts giving stock ratings to Lifestance Health Group Inc.
As of Jul, 6 of 8 firms rate LFST a Buy (2 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
LFST EPS & revenue forecast
EPS · NEXT QUARTER
$0.07
Range $0.06 – $0.08 · 5 analysts · +410% YoY
Next period, 5 analysts expect Lifestance Health Group Inc to earn $0.07 a share (range $0.06 – $0.08), versus $0.01 a year earlier. Full-year consensus is $0.31, growing to $0.39 the year after.
REVENUE · NEXT QUARTER
$418.5M
Range $415.6M – $425.2M · 5 analysts · +15% YoY
Revenue is expected to reach $418.5M (range $415.6M – $425.2M), +15.0% year-over-year. Full-year consensus is $1.7B, rising to $1.9B next year.
Top analysts covering Lifestance Health Group Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on LFST.
#1
Scott Schoenhaus
Keybanc · Rank #345
Buy
$9.00-20.0% to target
Overall win rate
29%
+ Follow
#2
David Larsen
BTIG
Buy
$15.00+33.3% to target
Coverage
—
+ Follow
#3
Kevin Caliendo
UBS
Buy
$13.00+15.6% to target
Coverage
—
+ Follow
#4
Richard Close
Canaccord Genuity
Buy
$13.00+15.6% to target
Coverage
—
+ Follow
#5
PW
Peter Warendorf
Barclays
Buy
$13.00+15.6% to target
Coverage
—
+ Follow
LFST stock forecast FAQ
What is LFST's average 12-month price target?+
The 8 analysts with a live target average $11.50 for Lifestance Health Group Inc over the next 12 months, ranging from a $15.00 high to a $8.00 low.
Is LFST stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 8 analyst ratings, 6 are Buy or Strong Buy, 2 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for LFST?+
The Street-high target is $15.00 (BTIG), and the Street-low is $8.00 (BMO Capital). The average of all 8 active targets is $11.50.
How many Wall Street analysts cover LFST?+
8 analysts have an active rating on Lifestance Health Group Inc, and 8 firms carry a live 12-month price target.
Who is the most accurate analyst covering LFST?+
Among analysts who currently cover LFST, Scott Schoenhaus of Keybanc has the strongest overall Quantellect track record (Rank #345). Their current call is Buy with a $9.00 target.
What is Lifestance Health Group Inc's projected EPS for next quarter?+
The consensus estimate is $0.07 per share (range $0.06 – $0.08) across 5 analysts. Full-year EPS is projected at $0.31, rising to $0.39 the following year.
How much revenue is Lifestance Health Group Inc expected to report next quarter?+
Consensus revenue is $418.5M (range $415.6M – $425.2M). Full-year revenue is projected at $1.7B, growing to $1.9B next year.
Have analysts been upgrading or downgrading LFST lately?+
As of Jul, 6 of 8 firms rate LFST a Buy (2 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their LFST calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
